Reperfusion paradox in ST-segment elevation myocardial infarction

Annals of Internal Medicine

Volumn 155, Issue 6, 2011, Pages

  Armstrong, Paul ^a   Boden, William ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Buffalo General Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; EVENT FREE SURVIVAL; FIBRINOLYSIS; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEART MUSCLE REPERFUSION; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNITED STATES; CORONARY CARE UNIT; FIBRINOLYTIC THERAPY; HEART INFARCTION; HOSPITAL; PATIENT REFERRAL; PRACTICE GUIDELINE; STANDARD; TIME; UTILIZATION REVIEW;

ANGIOPLASTY, BALLOON, CORONARY; CARDIAC CARE FACILITIES; ELECTROCARDIOGRAPHY; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; THROMBOLYTIC THERAPY; TIME FACTORS; UNITED STATES;

EID: 80052932274     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-155-6-201109200-00008     Document Type: Article

References (23)

1. Keeley EC. Boura JA. Grines CL,. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20. [PMID: 12517460]
2. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Et Al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/ American Heart Association Task Force On Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). 2004. Accessed at www.acc.org/clinical/guidelines/stemi/Guideline1.index.pdf on 20 May 2011.
3. Peterson ED, Ohman EM, Brindis RG, Cohen DJ, Magid DJ. Development of systems of care for ST-elevation myocardial infarction patients: evaluation and outcomes. Circulation. 2007;116:e64-67. [PMID: 17538037]
4. Gibson CM, Pride YB, Frederick PD, Pollack CV Jr, Canto JG, Tiefenbrunn AJ, et al. Trends in reperfusion strategies, door-to-needle and door-toballoon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J. 2008;156:1035-1044. [PMID: 19032997]
5. De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109:1223-1225. [PMID: 15007008]
6. Williams DO. Treatment delayed is treatment denied. Circulation. 2004;109: 1806-1808. [PMID: 15096459]
7. Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D, et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol. 2010;56:254-263. [PMID: 20633817]
8. Lambert L, Brown K, Segal E, Brophy J, Rodes-Cabau J, Bogaty P. Association between timeliness of reperfusion therapy and clinical outcomes in STelevation myocardial infarction. JAMA. 2010;303:2148-2155. [PMID: 20516415]
9. Nallamothu BK, Bates ER, Herrin J, Wang Y, Bradley EH, Krumholz HM; NRMI Investigators. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation. 2005;111:761-767. [PMID: 15699253]
10. Stone GW. Angioplasty strategies in ST-segment-elevation myocardial infarction: part I: primary percutaneous coronary intervention. Circulation. 2008;118: 538-551. [PMID: 18663102]
11. Bates ER, Nallamothu BK. Commentary: the role of percutaneous coronary intervention in ST-segment-elevation myocardial infarction. Circulation. 2008; 118:567-573. [PMID: 18663104]
12. Armstrong PW, Westerhout CM, Welsh RC. Duration of symptoms is the key modulator of the choice of reperfusion for ST-elevation myocardial infarction. Circulation. 2009;119:1293-1303. [PMID: 19273730]
13. Bates ER, Nallamothu BK. Commentary: the role of percutaneous coronary intervention in ST-segment-elevation myocardial infarction. Circulation. 2008; 118:567-573. [PMID: 18663104]
14. Verheugt FW, Gersh BJ, Armstrong PW. Aborted myocardial infarction: a new target for reperfusion therapy. Eur Heart J. 2006;27:901-904. [PMID: 16543251]
15. Terkelsen CJ, Sørensen JT, Maeng M, Jensen LO, Tilsted HH, Trautner S, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA. 2010;304:763-771. [PMID: 20716739]
16. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, et al; DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003; 349:733-742. [PMID: 12930925]
17. Westerhout CM, Bonnefoy E, Welsh RC, Steg PG, Boutitie F, Armstrong PW. The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: a pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST. Am Heart J. 2011;161:283-290. [PMID: 21315210]
18. Armstrong PW, Fu Y, Westerhout CM, Hudson MP, Mahaffey KW, White HD, et al. Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2009;53: 1503-1509. [PMID: 19389560]
19. Kadakia MB, Desai NR, Alexander KP, Chen AY, Foody JM, Cannon CP, et al; National Cardiovascular Data Registry. Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry-GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines). JACC Cardiovasc Interv. 2010;3:1166-1177. [PMID: 21087753]
20. Magid DJ, Wang Y, Herrin J, McNamara RL, Bradley EH, Curtis JP, et al. Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction. JAMA. 2005;294:803-812. [PMID: 16106005]
21. Morrow DA, Antman EM, Parsons L, de Lemos JA, Cannon CP, Giugliano RP, et al. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA. 2001;286:1356-1359. [PMID: 11560541]
22. Thune JJ, Hoefsten DE, Lindholm MG, Mortensen LS, Andersen HR, Nielsen TT, et al; Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI)-2 Investigators. Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty. Circulation. 2005;112: 2017-2021. [PMID: 16186438]
23. Henry TD, Sharkey SW, Burke MN, Chavez IJ, Graham KJ, Henry CR, et al. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation. 2007;116:721-728. [PMID: 17673457]